kininogen

  • n.激肽原
kininogenkininogen
  1. Objective : This paper was designed to analyze the effects of kinin free high molecular weight kininogen ( HKa ) on cell spreading to altered vitronectin ( aVN ) .

    目的:通过观察结构上改变的体外连接蛋白(aVN)底物上激活的高分子激肽原(HKa)对细胞伸展的影响,比较VN与aVN上HKa对细胞抑制活性。

  2. Potential Anti-tumor Function of Cleaved High Molecular Weight Kininogen and Its Molecular Mechanism

    活化型高分子量激肽原潜在的抗肿瘤作用及其分子机制

  3. Progress in the Study on Alternative Splicing and Functions of Kininogen Genes

    激肽原基因的选择性剪接与功能研究进展

  4. The kininogen gene and its coded proteins are slightly different in various species .

    激肽原基因在不同物种中有一定的差异,其编码的蛋白质产物也有所不同。

  5. Kininogen 1 could be detected in 100 % of vitreous and serum samples .

    激肽原1可以在所有的PVR患者玻璃体和血清样本中检测到(24/24100%)。

  6. Inhibition of Cell Spreading by Recombinant Histidine-rich Domain of High Molecular Weight Kininogen and Its Mechanism

    高分子量激肽原富含组氨酸区域抑制细胞伸展的机制分析

  7. Moreover , the enzyme hydrolyzed bovine low molecular mass kininogen and releasing bradykinin .

    另外,此酶能够水解牛低分子量的激肽原,释放舒缓激肽。

  8. Verification of kininogen 1 as a serum molecular marker of proliferative vitreoretinopathy

    激肽原1作为增生性玻璃体视网膜病变血清分子标志物的验证

  9. Distribution of T - Kininogen in rat 's lumbosacral segment of spinal cord and dorsal ganglion

    T-激肽原在大鼠腰骶髓及背根节的分布

  10. High molecular weight kininogen ( HK ) and low molecular weight kininogen are selective inhibitors of thrombin induced platelet activation .

    高分子量激肽原和低分子量激肽原能选择性抑制凝血酶诱导的血小板活化;

  11. The Relationship Between Anti-Cell Spreading of Kinin-Free High Molecular Weight Kininogen and the Conformational State of Vitronectin

    激活的高分子激肽原抗细胞伸展与体外连接蛋白结构变化关系的探讨

  12. Tissue kallikrein belongs to a subgroup of serine proteinases and processes low molecular weight kininogen substrate to release vasoactive kinin peptides .

    激肽释放酶是一种丝氨酸蛋白酶,可将低分子量的激肽原分解释放出有血管活性的激肽。

  13. Combined therapy of kallidinogenase and irbesartan for early period type 2 diabetic nephropathy of elderly patients Verification of kininogen 1 as a serum molecular marker of proliferative vitreoretinopathy

    厄贝沙坦联合胰激肽原酶治疗老年早期糖尿病肾病的观察激肽原1作为增生性玻璃体视网膜病变血清分子标志物的验证

  14. Among the PVR special proteins , kininogen 1 was one of the relatively high abundance proteins of which more peptides could be identified ; IGFBP-6 was involved in signal transduction .

    在PVR特异的蛋白质中,激肽原1是鉴定到的肽段数较多大的相对高丰度蛋白质;而IGFBP-6与增殖的信号转导有关。

  15. Contact system is the beginning of intrinsic coagulation pathway and comprises four components : high molecular weight kininogen , prekallikrein , factor XII ( FXII ) and factor XI ( FXI ) .

    内源性凝血途径的起始部分称为接触系统,包括高分子量激肽原、前激肽释放酶、XII因子和XI因子。

  16. A kininogen was purified from chum salmon plasma with one step of papain affinity chromatography . The recovery , specific inhibitory activity and purification fold were 0.94 % , 3.84 U / mg and 30.36 , respectively .

    通过使用木瓜蛋白酶亲和柱,从鲑鱼血浆中纯化出了一种kiniongen,该纯化的回收率、比活力和纯化倍数分别为0.94%、3.84U/mg和30.36倍。

  17. AIM : To study the effect of domain 5 of the active high molecular weight kininogen ( HKa ) on the vitronectin-mediated adhesion and migration and angiogenesis of human umbilical vein endothelial cells ( HUVECs ) in vitro .

    目的:体外实验研究活化型高分子量激肽原(HKa)轻链富含组氨酸区域5(HKD5)对人脐静脉内皮细胞(HUVECs)的粘附、游走及血管形成的影响。